Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
The Relapsing-Remitting Multiple Sclerosis (MS) patients research has revealed that the matrix metalloproteinase-2 level in cerebrospinal fluid which is higher then 30 ng/ml during the relapse and/or remission period increases repeated relapse risk during 2 years term by 2.8 times. The rapid MS prog...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2010-08-01
|
| Series: | Bûlleten' Sibirskoj Mediciny |
| Subjects: | |
| Online Access: | https://bulletin.tomsk.ru/jour/article/view/1646 |